Acarix: Comments on rights issue and coverage resumed
Research Note
2023-01-04
10:45
Redeye resumes its coverage and comments on the outcome of Acarix’s rights issue. We will return early next week with a more elaborate research update.
FE
Filip Einarsson
Disclosures and disclaimers